Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy
Open Access
- 1 June 1973
- Vol. 31 (6) , 1367-1373
- https://doi.org/10.1002/1097-0142(197306)31:6<1367::aid-cncr2820310611>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Doxorubicin in DisseminatedPublished by American Medical Association (AMA) ,1972
- Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancerCancer, 1972
- Renal toxicity of methotrexateCancer, 1969
- Carrier-mediated Transport of the Folic Acid Analogue, Methotrexate, in the L1210 Leukemia CellJournal of Biological Chemistry, 1968
- An Analysis of Thirty Patients Surviving Longer than Ten Years after Treatment for Osteogenic SarcomaJournal of Bone and Joint Surgery, 1968
- Toxicity and Antitumor Effect Of Divided Doses of MethotrexateArchives of internal medicine (1960), 1965
- Osteosarcoma. A study of the value of preoperative megavoltage radiotherapyBritish Journal of Surgery, 1964
- Combination Therapy of Malignant Hemangioendothelioma with Radiation and MethotrexateRadiology, 1962
- Inhibition of Dihydrofolic Reductase by Aminopterin and Amethopterin.Experimental Biology and Medicine, 1958